Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc > i finally have figured out why run rate 2m in Dec 2021

<< Previous

Bullboard Posts

Next >>

Comment by TimSanderson Oct 08, 2022 11:05pm

86 Views

Post# 35014506

RE:i finally have figured out why run rate 2m in Dec 2021

mingzhu wrote: with 40k patients resulted only in $1m SaaS revenue in Q1 2022. First, 3 months revenue delay, second, it took 6 months for new boarded patients to comply from 0 to 60%, 12 months to 80%, and 90% thereafter. That means those 40k patients only be fully billable 90% in Q1 2023, not 2022. CEO did not exagerate the run rate and 40k patients on board.

Here are my revenue calculations based on compliance rate from 0 to 90% in comparison with real reported SaaS revenue in the past 3 Qs :

reported revenue: 364k(?) 525k 1,067k
My calcualtions : 265k 580k 966k

I put ? on the 364k because i did not see 1.6m revenue breakdown of soft and hardware in that Q report. I took it from Investor22 number. Investor22 may has to check the number again or give the source. People can see my calculations are really close to real numbers. Therefor I am so confident my estimated SaaS 1.9m revenue is very close to real number in incoming report. As for the 3.1m hardware revenue, it may be overstated a little because i presume every new patient needs a device, but that is not true. play on n safe side, the total revenue should be in the range $ 4m to $5.1m.